[Effect of gastrin on esophageal motility].
D000752:Anemia, Pernicious / Q000503:physiopathology; D000818:Animals; D002766:Cholecystokinin / Q000494:pharmacology; D004931:Esophageal Achalasia / Q000503:physiopathology; D004943:Esophagogastric Junction / Q000187:drug effects; D004947:Esophagus / Q000187:drug effects*; D004958:Estradiol / Q000494:pharmacology; D005750:Gastric Juice; D005755:Gastrins / Q000008:administration & dosage / Q000494:pharmacology* / Q000502:physiology; D005934:Glucagon / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D009893:Opossums; D011312:Pressure; D011374:Progesterone / Q000494:pharmacology; D012633:Secretin / Q000494:pharmacology; D015043:Zollinger-Ellison Syndrome / Q000503:physiopathology
D005755:Gastrins; D012633:Secretin; D011374:Progesterone; D004958:Estradiol; D005934:Glucagon; D002766:Cholecystokinin
Der Effekt von Gastrin auf die Osophagusmotilität.